EXFORGE
Live / Registered — Registered and renewed (as of 14 Aug 2023)
What this means for you
Registered since 16 Sept 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Sept 2023).
Record
- Serial number
- 78089458
- Registration number
- 2764146
- Mark type
- Word mark
- Filed
- 22 Oct 2001
- Published for opposition
- 24 Jun 2003
- Registered
- 16 Sept 2003
- Next maintenance due
- 16 Sept 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF [ THE CENTRAL NERVOUS SYSTEM, THE IMMUNE SYSTEM, ] THE CARDIO-VASCULAR SYSTEM [, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, FOR THE TREATMENT OF INFLAMMATORY DISORDERS, FOR THE TREATMENT OF SKIN DISORDERS, FOR THE TREATMENT OF CANCER, AND FOR THE TREATMENT OF EYE DISORDERS ]
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 14 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Aug 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 14 Aug 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jan 2023 — TEAS SECTION 8 & 9 RECEIVED
- 16 Sept 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Jun 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Jun 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Jun 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Jun 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jun 2013 — TEAS SECTION 8 & 9 RECEIVED
- 25 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Feb 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 17 Feb 2009 — ASSIGNED TO PARALEGAL
- 12 Feb 2009 — TEAS SECTION 8 RECEIVED